vs

Side-by-side financial comparison of SIFCO INDUSTRIES INC (SIF) and Entrada Therapeutics, Inc. (TRDA). Click either name above to swap in a different company.

SIFCO INDUSTRIES INC is the larger business by last-quarter revenue ($24.0M vs $20.6M, roughly 1.2× Entrada Therapeutics, Inc.). SIFCO INDUSTRIES INC runs the higher net margin — 7.5% vs -84.4%, a 91.9% gap on every dollar of revenue. On growth, SIFCO INDUSTRIES INC posted the faster year-over-year revenue change (14.8% vs -65.2%). SIFCO INDUSTRIES INC produced more free cash flow last quarter ($8.0M vs $-39.7M). Over the past eight quarters, SIFCO INDUSTRIES INC's revenue compounded faster (8.1% CAGR vs 6.4%).

SIFCO Industries, Inc. (SIFCO), is a global metal component manufacturer based in Cleveland, Ohio.

Entrada Therapeutics is a clinical-stage biotechnology firm developing transformative intracellular therapies for serious rare diseases and high-unmet-need disorders. Its pipeline covers neuromuscular, metabolic, and central nervous system segments, serving global patients via healthcare partnerships.

SIF vs TRDA — Head-to-Head

Bigger by revenue
SIF
SIF
1.2× larger
SIF
$24.0M
$20.6M
TRDA
Growing faster (revenue YoY)
SIF
SIF
+80.0% gap
SIF
14.8%
-65.2%
TRDA
Higher net margin
SIF
SIF
91.9% more per $
SIF
7.5%
-84.4%
TRDA
More free cash flow
SIF
SIF
$47.6M more FCF
SIF
$8.0M
$-39.7M
TRDA
Faster 2-yr revenue CAGR
SIF
SIF
Annualised
SIF
8.1%
6.4%
TRDA

Income Statement — Q1 FY2026 vs Q1 FY2025

Metric
SIF
SIF
TRDA
TRDA
Revenue
$24.0M
$20.6M
Net Profit
$1.8M
$-17.3M
Gross Margin
21.6%
Operating Margin
10.7%
-106.0%
Net Margin
7.5%
-84.4%
Revenue YoY
14.8%
-65.2%
Net Profit YoY
177.3%
-173.8%
EPS (diluted)
$0.29
$-0.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SIF
SIF
TRDA
TRDA
Q4 25
$24.0M
Q3 25
$22.8M
Q2 25
$22.1M
Q1 25
$19.0M
$20.6M
Q4 24
$20.9M
$37.4M
Q3 24
$21.7M
$19.6M
Q2 24
$22.0M
$94.7M
Q1 24
$20.5M
$59.1M
Net Profit
SIF
SIF
TRDA
TRDA
Q4 25
$1.8M
Q3 25
$-429.0K
Q2 25
$3.4M
Q1 25
$-1.4M
$-17.3M
Q4 24
$-2.3M
$1.1M
Q3 24
$-443.0K
$-14.0M
Q2 24
$72.0K
$55.0M
Q1 24
$-1.6M
$23.5M
Gross Margin
SIF
SIF
TRDA
TRDA
Q4 25
21.6%
Q3 25
9.6%
Q2 25
26.7%
Q1 25
8.3%
Q4 24
4.4%
Q3 24
10.7%
Q2 24
12.3%
Q1 24
7.3%
Operating Margin
SIF
SIF
TRDA
TRDA
Q4 25
10.7%
Q3 25
-1.7%
Q2 25
14.8%
Q1 25
-4.1%
-106.0%
Q4 24
-9.2%
-15.7%
Q3 24
-1.5%
-110.7%
Q2 24
0.7%
56.4%
Q1 24
-6.5%
35.7%
Net Margin
SIF
SIF
TRDA
TRDA
Q4 25
7.5%
Q3 25
-1.9%
Q2 25
15.4%
Q1 25
-7.3%
-84.4%
Q4 24
-11.1%
3.0%
Q3 24
-2.0%
-71.7%
Q2 24
0.3%
58.1%
Q1 24
-7.8%
39.7%
EPS (diluted)
SIF
SIF
TRDA
TRDA
Q4 25
$0.29
Q3 25
$-0.07
Q2 25
$0.56
Q1 25
$-0.23
$-0.42
Q4 24
$-0.38
$-0.20
Q3 24
$-0.07
$-0.35
Q2 24
$0.01
$1.55
Q1 24
$-0.27
$0.68

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SIF
SIF
TRDA
TRDA
Cash + ST InvestmentsLiquidity on hand
$1.1M
$67.8M
Total DebtLower is stronger
$39.0K
Stockholders' EquityBook value
$38.7M
$417.3M
Total Assets
$74.9M
$486.5M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SIF
SIF
TRDA
TRDA
Q4 25
$1.1M
Q3 25
$491.0K
Q2 25
$2.0M
Q1 25
$1.9M
$67.8M
Q4 24
$3.1M
$101.2M
Q3 24
$1.7M
$78.0M
Q2 24
$3.4M
$185.3M
Q1 24
$2.5M
$68.4M
Total Debt
SIF
SIF
TRDA
TRDA
Q4 25
$39.0K
Q3 25
$51.0K
Q2 25
Q1 25
Q4 24
Q3 24
$0
Q2 24
$3.6M
Q1 24
$4.1M
Stockholders' Equity
SIF
SIF
TRDA
TRDA
Q4 25
$38.7M
Q3 25
$36.9M
Q2 25
$35.8M
Q1 25
$32.4M
$417.3M
Q4 24
$33.7M
$428.7M
Q3 24
$30.4M
$422.4M
Q2 24
$29.8M
$429.9M
Q1 24
$29.7M
$269.4M
Total Assets
SIF
SIF
TRDA
TRDA
Q4 25
$74.9M
Q3 25
$73.4M
Q2 25
$77.3M
Q1 25
$78.8M
$486.5M
Q4 24
$81.0M
$526.3M
Q3 24
$104.6M
$554.6M
Q2 24
$106.3M
$582.0M
Q1 24
$104.2M
$510.8M
Debt / Equity
SIF
SIF
TRDA
TRDA
Q4 25
0.00×
Q3 25
0.00×
Q2 25
Q1 25
Q4 24
Q3 24
0.00×
Q2 24
0.12×
Q1 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SIF
SIF
TRDA
TRDA
Operating Cash FlowLast quarter
$8.1M
$-38.5M
Free Cash FlowOCF − Capex
$8.0M
$-39.7M
FCF MarginFCF / Revenue
33.3%
-192.9%
Capex IntensityCapex / Revenue
0.4%
5.6%
Cash ConversionOCF / Net Profit
4.51×
TTM Free Cash FlowTrailing 4 quarters
$11.5M
$-58.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SIF
SIF
TRDA
TRDA
Q4 25
$8.1M
Q3 25
$726.0K
Q2 25
$371.0K
Q1 25
$2.8M
$-38.5M
Q4 24
$-3.8M
$-31.6M
Q3 24
$857.0K
$-24.3M
Q2 24
$382.0K
$39.8M
Q1 24
$-3.2M
$-25.5M
Free Cash Flow
SIF
SIF
TRDA
TRDA
Q4 25
$8.0M
Q3 25
$566.0K
Q2 25
$310.0K
Q1 25
$2.7M
$-39.7M
Q4 24
$-3.9M
$-32.2M
Q3 24
$580.0K
$-24.9M
Q2 24
$-175.0K
$38.8M
Q1 24
$-3.9M
$-26.4M
FCF Margin
SIF
SIF
TRDA
TRDA
Q4 25
33.3%
Q3 25
2.5%
Q2 25
1.4%
Q1 25
14.1%
-192.9%
Q4 24
-18.8%
-86.2%
Q3 24
2.7%
-127.3%
Q2 24
-0.8%
41.0%
Q1 24
-18.9%
-44.6%
Capex Intensity
SIF
SIF
TRDA
TRDA
Q4 25
0.4%
Q3 25
0.7%
Q2 25
0.3%
Q1 25
0.8%
5.6%
Q4 24
0.5%
1.7%
Q3 24
1.3%
3.3%
Q2 24
2.5%
1.1%
Q1 24
3.3%
1.4%
Cash Conversion
SIF
SIF
TRDA
TRDA
Q4 25
4.51×
Q3 25
Q2 25
0.11×
Q1 25
Q4 24
-27.94×
Q3 24
Q2 24
5.31×
0.72×
Q1 24
-1.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SIF
SIF

Fixed Wing Aircraft Revenue$10.5M44%
Commercial Revenue$8.7M36%
Commercial Product And Other Revenue$2.8M12%
Commercial Space$1.1M5%
Other$840.0K4%

TRDA
TRDA

Segment breakdown not available.

Related Comparisons